This work provides a systematic review of the literature from January 2003 to April 2014
pertaining to the incidence, pathophysiology, diagnosis, and treatment of osteonecrosis of the …

BACKGROUND:: Bone mineral density (BMD) measurementsare the standard tool in the
diagnosis of osteoporosis. However, recent developments in bone research show that a BMD …

Whole-body vibration (WBV) is receiving increasing interest as a therapeutic modality to
improve neuromuscular performance or to increase bone mass or density. In order to help …

… vitamin D according to their serum 25-OH D levels (800 IU for patients having serum 25-OH
D lower … For patients with severe vitamin D deficiency (25-OH D lower than 30 nmol/liter) the …

ONJ has been increasingly suspected to be a potential complication of bisphosphonate
therapy in recent years. Thus, the ASBMR leadership appointed a multidisciplinary task force to …

Our aim was to determine the prevalence of radiographically defined vertebral deformity, as
a marker of vertebral osteoporosis, in different regions and populations within Europe. We …

Oral daily (2.5 mg) and intermittent ibandronate (between‐dose interval of >2 months),
delivering a similar cumulative exposure, were evaluated in 2946 osteoporotic women with …

Dosing convenience is a key element in the effective management of any chronic disease,
and is particularly important in the long-term management of osteoporosis. Less frequent …

… Levels of 25-hydroxyvitamin D were determined before study entry. Excluded from
participation were women with metabolic bone disease other than postmenopausal osteoporosis; …

… months, evidence of secondary osteoporosis, clinical or laboratory evidence of hepatic or
renal disease, disorders of the parathyroid or thyroid glands, a serum 25-hydroxyvitamin D …